Study Details

8409-184-Group 6

Back To Current Studies

Healthy Non-Smoking Adults Needed

Study Number

8409-184-Group 6

Group

6

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Jan. 23 - May 29, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Jan 17, 20

Check-in: Jan 23, 2020

Check-out: Jan 31, 2020

Outpatient Visits: Feb 3, 7, 14, 21; Mar 6, 20; Apr 3, 17; May 1, 15, 29

Study Number

8409-184-Group 6

Group

6

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Jan. 23 - May 29, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Jan 17, 20

Check-in: Jan 23, 2020

Check-out: Jan 31, 2020

Outpatient Visits: Feb 3, 7, 14, 21; Mar 6, 20; Apr 3, 17; May 1, 15, 29

Calculate Your BMI!

Calculate Your BMI!